Insider · CIK 0001709959
Susan M Podlogar
Files at MET (METLIFE INC), LIVN (LivaNova PLC), TVGN (Tevogen Bio Holdings Inc.). First filing -, latest -.
In brief
Susan M Podlogar files SEC Form 4 as director and officer at MET (METLIFE INC), and also at LIVN (LivaNova PLC), TVGN (Tevogen Bio Holdings Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Susan M Podlogar has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 17 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 11, 2026 | TVGN Tevogen Bio Holdings Inc. | AGrant or award Common Stock | +75,000 | $0.00 | $0 | 123,678 | 29 d ago |
| Jul 10, 2026 | TVGN Tevogen Bio Holdings Inc. | AGrant or award Common Stock | +40,000 | $0.00 | $0 | 48,678 | Jul 10, 2026 |
| Jun 15, 2026 | LIVN LivaNova PLC | MOption exercise Ordinary Shares | +4,042 | $0.00 | $0 | 6,128 | Jun 17, 2026 |
| Jun 15, 2026 | LIVN LivaNova PLC | FTax withholding Ordinary Shares | -486 | $79.70 | $39k | 5,642 | Jun 17, 2026 |
| Jun 15, 2026 | LIVN LivaNova PLC | MOption exercise Restricted Stock Unitsderivative | -4,042 | $0.00 | $0 | 0 | Jun 17, 2026 |
| Jun 15, 2026 | LIVN LivaNova PLC | AGrant or award Restricted Stock Unitsderivative | +2,383 | $0.00 | $0 | 2,383 | Jun 17, 2026 |
| Dec 15, 2025 | LIVN LivaNova PLC | MOption exercise Ordinary Shares | +2,355 | $0.00 | $0 | 2,355 | Dec 17, 2025 |
| Dec 15, 2025 | LIVN LivaNova PLC | FTax withholding Ordinary Shares | -269 | $63.06 | $17k | 2,086 | Dec 17, 2025 |
| Dec 15, 2025 | LIVN LivaNova PLC | MOption exercise Restricted Stock Unitsderivative | -2,355 | $0.00 | $0 | 0 | Dec 17, 2025 |
| Jun 15, 2025 | LIVN LivaNova PLC | AGrant or award Restricted Stock Unitsderivative | +4,042 | $0.00 | $0 | 4,042 | Jun 17, 2025 |
| Dec 23, 2024 | TVGN Tevogen Bio Holdings Inc. | AGrant or award Common Stock | +240,000 | $0.00 | $0 | 433,923 | Dec 26, 2024 |
| Dec 15, 2024 | LIVN LivaNova PLC | AGrant or award Restricted Stock Unitsderivative | +2,355 | $0.00 | $0 | 2,355 | Dec 17, 2024 |
| Mar 1, 2024 | MET METLIFE INC | FTax withholding Common Stock | -1,907 | $69.73 | $133k | 79,794 | Mar 5, 2024 |
| Feb 27, 2024 | MET METLIFE INC | AGrant or award Common Stock | +4,013 | - | - | 68,555 | Feb 29, 2024 |
| Feb 27, 2024 | MET METLIFE INC | AGrant or award Common Stock | +26,968 | - | - | 95,523 | Feb 29, 2024 |
| Feb 27, 2024 | MET METLIFE INC | FTax withholding Common Stock | -13,822 | $69.16 | $956k | 81,701 | Feb 29, 2024 |
| Feb 27, 2024 | MET METLIFE INC | AGrant or award Employee Stock Options (right to buy)derivative | +12,040 | $0.00 | $0 | 12,040 | Feb 29, 2024 |
Questions about Susan M Podlogar
Answered from the filings on this page, as of the latest one.
Is Susan M Podlogar buying or selling?
Susan M Podlogar has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Susan M Podlogar's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Susan M Podlogar has 0.
Where does Susan M Podlogar file Form 4?
Susan M Podlogar has filed Form 4 at MET (METLIFE INC) as EVP & Chief HR Officer; LIVN (LivaNova PLC); TVGN (Tevogen Bio Holdings Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.